Along with particulate control and determination, speakers at the June conference in Rockville, Maryland, examined the role of protein aggregation and immunogenicity
Maura C. Kibbey, PhD
Advertisement
Maura C. Kibbey is director of science and standards, USP Global Biologics.
Articles by Maura C. Kibbey, PhD
USP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
Advertisement
Latest Updated Articles
- Standards-Setting Activities on Impurities
Published: March 1st 2013 | Updated:
- First USP Workshop of its Kind Focuses on Particulates in Biologics
Published: September 14th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
